Int J Epidemiol:艾滋病乙肝梅毒三病联合母婴阻断策略找到

2019-04-15 不详 西安交大公共卫生学院

2017年10月,世界卫生组织(WHO)西太区委员会通过了2018-2030年亚洲及太平洋地区艾滋病、乙肝和梅毒三病联合母婴阻断的干预框架,提出了整合干预方案以持续有效地降低并最终消除这三种传染病的母婴传播。为回应WHO的建议,公共卫生学院张磊教授利用柬埔寨孕产妇人群数据,构建了数学预测模型,评估了该整合干预方案的疾病控制效果和成本效果。近日,该研究成果“Integrated approach f

2017年10月,世界卫生组织(WHO)西太区委员会通过了2018-2030年亚洲及太平洋地区艾滋病、乙肝和梅毒三病联合母婴阻断的干预框架,提出了整合干预方案以持续有效地降低并最终消除这三种传染病的母婴传播。为回应WHO的建议,公共卫生学院张磊教授利用柬埔寨孕产妇人群数据,构建了数学预测模型,评估了该整合干预方案的疾病控制效果和成本效果。近日,该研究成果“Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation”在International Journal of Epidemiology杂志在线发表。

柬埔寨目前艾滋病、乙肝和梅毒的母婴传播率分别为6.6%,14.1%和9.4%,花费在这三种传染病母婴阻断上的费用每年高达230万美元,除常规新生儿乙肝疫苗接种外,尚无针对乙肝母婴阻断的干预措施。研究显示,若将艾滋病和梅毒干预整合到现有产前保健体系内,则每年可减少38万美元开支,且能使艾滋病和梅毒的母婴传播率分别降至6.1%和4.6%;若给携带乙肝病毒的母亲分娩的婴儿增加乙肝免疫球蛋白注射,则总干预费用为每年330万美元,能使乙肝母婴传播率降至5.0%;若针对乙肝高病毒载量孕妇提供抗病毒治疗,则总干预费用为每年440万美元,能使乙肝母婴传播率降至3.5%;若同时采取以上两种乙肝母婴阻断措施,则总干预费用增至每年450万美元,并能使乙肝母婴传播率降至3.4%。上述干预措施均具有较高的成本效果(每避免一个伤残调整寿命年只需64 美元~114美元),而且整合干预远比分开干预更具经济效益,显示了三病联合母婴阻断策略在发展中国家极具可行性。

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=884713, encodeId=6ced884e130d, content=<a href='/topic/show?id=a48786e89c1' target=_blank style='color:#2F92EE;'>#艾滋病#</a><a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a><a href='/topic/show?id=3ee36352243' target=_blank style='color:#2F92EE;'>#母婴传播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86789, encryptionId=a48786e89c1, topicName=艾滋病), TopicDto(id=23419, encryptionId=cf292341925, topicName=乙肝), TopicDto(id=63522, encryptionId=3ee36352243, topicName=母婴传播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Sep 12 10:03:49 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710186, encodeId=9a811e10186d4, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Wed Oct 30 11:56:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005108, encodeId=669e2005108d1, content=<a href='/topic/show?id=e052635332c' target=_blank style='color:#2F92EE;'>#母婴阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63533, encryptionId=e052635332c, topicName=母婴阻断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Wed Aug 21 17:56:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439383, encodeId=084c14393830c, content=<a href='/topic/show?id=45616352128' target=_blank style='color:#2F92EE;'>#母婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63521, encryptionId=45616352128, topicName=母婴)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 12:56:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364712, encodeId=37ee364e1297, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Apr 15 22:33:36 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364709, encodeId=e4b0364e093a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 15 22:04:53 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=884713, encodeId=6ced884e130d, content=<a href='/topic/show?id=a48786e89c1' target=_blank style='color:#2F92EE;'>#艾滋病#</a><a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a><a href='/topic/show?id=3ee36352243' target=_blank style='color:#2F92EE;'>#母婴传播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86789, encryptionId=a48786e89c1, topicName=艾滋病), TopicDto(id=23419, encryptionId=cf292341925, topicName=乙肝), TopicDto(id=63522, encryptionId=3ee36352243, topicName=母婴传播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Sep 12 10:03:49 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710186, encodeId=9a811e10186d4, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Wed Oct 30 11:56:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005108, encodeId=669e2005108d1, content=<a href='/topic/show?id=e052635332c' target=_blank style='color:#2F92EE;'>#母婴阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63533, encryptionId=e052635332c, topicName=母婴阻断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Wed Aug 21 17:56:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439383, encodeId=084c14393830c, content=<a href='/topic/show?id=45616352128' target=_blank style='color:#2F92EE;'>#母婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63521, encryptionId=45616352128, topicName=母婴)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 12:56:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364712, encodeId=37ee364e1297, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Apr 15 22:33:36 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364709, encodeId=e4b0364e093a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 15 22:04:53 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=884713, encodeId=6ced884e130d, content=<a href='/topic/show?id=a48786e89c1' target=_blank style='color:#2F92EE;'>#艾滋病#</a><a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a><a href='/topic/show?id=3ee36352243' target=_blank style='color:#2F92EE;'>#母婴传播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86789, encryptionId=a48786e89c1, topicName=艾滋病), TopicDto(id=23419, encryptionId=cf292341925, topicName=乙肝), TopicDto(id=63522, encryptionId=3ee36352243, topicName=母婴传播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Sep 12 10:03:49 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710186, encodeId=9a811e10186d4, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Wed Oct 30 11:56:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005108, encodeId=669e2005108d1, content=<a href='/topic/show?id=e052635332c' target=_blank style='color:#2F92EE;'>#母婴阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63533, encryptionId=e052635332c, topicName=母婴阻断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Wed Aug 21 17:56:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439383, encodeId=084c14393830c, content=<a href='/topic/show?id=45616352128' target=_blank style='color:#2F92EE;'>#母婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63521, encryptionId=45616352128, topicName=母婴)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 12:56:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364712, encodeId=37ee364e1297, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Apr 15 22:33:36 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364709, encodeId=e4b0364e093a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 15 22:04:53 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=884713, encodeId=6ced884e130d, content=<a href='/topic/show?id=a48786e89c1' target=_blank style='color:#2F92EE;'>#艾滋病#</a><a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a><a href='/topic/show?id=3ee36352243' target=_blank style='color:#2F92EE;'>#母婴传播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86789, encryptionId=a48786e89c1, topicName=艾滋病), TopicDto(id=23419, encryptionId=cf292341925, topicName=乙肝), TopicDto(id=63522, encryptionId=3ee36352243, topicName=母婴传播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Sep 12 10:03:49 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710186, encodeId=9a811e10186d4, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Wed Oct 30 11:56:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005108, encodeId=669e2005108d1, content=<a href='/topic/show?id=e052635332c' target=_blank style='color:#2F92EE;'>#母婴阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63533, encryptionId=e052635332c, topicName=母婴阻断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Wed Aug 21 17:56:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439383, encodeId=084c14393830c, content=<a href='/topic/show?id=45616352128' target=_blank style='color:#2F92EE;'>#母婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63521, encryptionId=45616352128, topicName=母婴)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 12:56:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364712, encodeId=37ee364e1297, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Apr 15 22:33:36 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364709, encodeId=e4b0364e093a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 15 22:04:53 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
    2019-04-17 zhouqu_8
  5. [GetPortalCommentsPageByObjectIdResponse(id=884713, encodeId=6ced884e130d, content=<a href='/topic/show?id=a48786e89c1' target=_blank style='color:#2F92EE;'>#艾滋病#</a><a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a><a href='/topic/show?id=3ee36352243' target=_blank style='color:#2F92EE;'>#母婴传播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86789, encryptionId=a48786e89c1, topicName=艾滋病), TopicDto(id=23419, encryptionId=cf292341925, topicName=乙肝), TopicDto(id=63522, encryptionId=3ee36352243, topicName=母婴传播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Sep 12 10:03:49 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710186, encodeId=9a811e10186d4, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Wed Oct 30 11:56:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005108, encodeId=669e2005108d1, content=<a href='/topic/show?id=e052635332c' target=_blank style='color:#2F92EE;'>#母婴阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63533, encryptionId=e052635332c, topicName=母婴阻断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Wed Aug 21 17:56:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439383, encodeId=084c14393830c, content=<a href='/topic/show?id=45616352128' target=_blank style='color:#2F92EE;'>#母婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63521, encryptionId=45616352128, topicName=母婴)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 12:56:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364712, encodeId=37ee364e1297, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Apr 15 22:33:36 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364709, encodeId=e4b0364e093a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 15 22:04:53 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
    2019-04-15 orangesking

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=884713, encodeId=6ced884e130d, content=<a href='/topic/show?id=a48786e89c1' target=_blank style='color:#2F92EE;'>#艾滋病#</a><a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a><a href='/topic/show?id=3ee36352243' target=_blank style='color:#2F92EE;'>#母婴传播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86789, encryptionId=a48786e89c1, topicName=艾滋病), TopicDto(id=23419, encryptionId=cf292341925, topicName=乙肝), TopicDto(id=63522, encryptionId=3ee36352243, topicName=母婴传播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Sep 12 10:03:49 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710186, encodeId=9a811e10186d4, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Wed Oct 30 11:56:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005108, encodeId=669e2005108d1, content=<a href='/topic/show?id=e052635332c' target=_blank style='color:#2F92EE;'>#母婴阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63533, encryptionId=e052635332c, topicName=母婴阻断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Wed Aug 21 17:56:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439383, encodeId=084c14393830c, content=<a href='/topic/show?id=45616352128' target=_blank style='color:#2F92EE;'>#母婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63521, encryptionId=45616352128, topicName=母婴)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 12:56:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364712, encodeId=37ee364e1297, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Apr 15 22:33:36 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364709, encodeId=e4b0364e093a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 15 22:04:53 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
    2019-04-15 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

57岁,我成了中国存活最久的艾滋病人

在中国,孟林是“国内已知的发病后存活时间最长的艾滋病病人”,自1995年初确诊感染艾滋病毒发病至今,已逾24年。在此期间,因在艾滋病感染者联盟秘书处以及爱之方舟感染者信息支持组织的工作,不断为艾滋病群体发声,孟林获得了“贝利.马丁”奖,以及联合国艾滋病规划署特别贡献奖。

葛兰素史克的双药片剂Dovato治疗艾滋病获FDA批准上市

美国食品和药物管理局已经批准了双药片剂艾滋病的治疗方案Dovato。Dovato(dolutegravir / lamivudine)由葛兰素史克领导的合资企业ViiV销售,是第一个用于治疗未接受过治疗患者的双药片剂。

北大BMJ重磅!AIDS是降低全球健康期望寿命的首要原因!NEJM连发2文,PD-1/PD-L1联合治疗大PK!

聚焦四大医学期刊,盘点最新研究热点。梅斯医研社,中国医学精英的内容头等舱。

Nat Microbiol:中国学者发现人类新型抗艾滋病毒蛋白PSGL-1,助力新型抗艾滋病药物研究

PSGL-1具有多重抗病毒功能,包括抑制病毒DNA复制和抑制新生病毒颗粒的新一轮感染。艾滋病毒通过其附属蛋白Vpu对PSGL-1进行结合并促进PSGL-1的降解,从而逃逸PSGL-1的抗病毒功能。研究Vpu和PSGL-1的结合抑制剂为新型抗艾滋病药物提供了新的途径。

当医护遇见艾滋病你会如何保护自己?

张爱玲在《爱》中写道,于千万人之中遇见你所遇见的人,于千万年时间无涯的荒野里,没有早一步,也没有晚一步,刚巧赶上了。

让人吓破胆的艾滋病真的没办法被治愈吗?或许基因会给你个惊喜

理论上讲,如果CCR5基因出现变异或缺失,人体就能自然免疫HIV 病毒!前不久一条新闻在圈内炸开了锅:“一对名为露露和娜娜的基因编辑婴儿于11月在中国健康诞生。这对双胞胎的一个基因经过修改,使她们出生后即能天然抵抗艾滋病。”在引起争议的同时,也让大家一时间聚焦到基因与艾滋病的关联上来。基因是怎么影响艾滋病的?根据新闻报道,研究人员们是在受精卵中,通过基因编辑技术,对CCR5基因进行的修改。那CCR